COMMUNIQUÉS West-GlobeNewswire

eFFECTOR Therapeutics Presents Preclinical Data for eFT508 that Demonstrates Beneficial Immunological Effects
10/11/2017
SAN DIEGO, Nov. 10, 2017 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc., a leader in the development of selective translation regulators (STRs) for the treatment of cancer, today announced a poster presentation of [...]
RavenQuest Announces Formal Agreement With Western Agripharma Limited
10/11/2017
VANCOUVER, British Columbia, Nov. 10, 2017 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) is pleased to announce it has entered into an agreement with Western Agripharma Limited [...]
Teligent, Inc. Announces FDA Approval of Betamethasone Dipropionate Ointment USP (Augmented), 0.05%
10/11/2017
BUENA, N.J., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT ), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
OrthoPediatrics Corp. to Present at Stifel 2017 Healthcare Conference
10/11/2017
WARSAW, Ind., Nov. 10, 2017 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS ), a company exclusively focused on advancing the field of pediatric orthopedics, announced today that Mark [...]
Oxford Immunotec to Present at the Jefferies 2017 London Healthcare Conference
10/11/2017
OXFORD, United Kingdom and MARLBOROUGH, Mass., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Oxford Immunotec Global PLC (Nasdaq: OXFD ), a global, high-growth diagnostics company focused on developing and commercializing [...]
Adaptimmune Presents Study Designs for Ongoing MAGE-A4 and NY-ESO SPEAR T-cell Clinical Trials at the Society for Immunotherapy of Cancer (SITC) Annual Meeting
10/11/2017
PHILADELPHIA and OXFORD, U.K., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Adaptimmune Therapeutics plc (Nasdaq: ADAP ), a leader in T-cell therapy to treat cancer, is presenting two trials in progress posters summarizing study [...]
Vilacto Bio Inc. in final stage of developing Anti-Aging Products
10/11/2017
COPENHAGEN, Denmark, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Vilacto Bio Inc. (OTC QB:VIBI), announces that it is in the final stage of developing its new anti-aging skin care line. The company is extremely hopeful with the [...]
Dova Pharmaceuticals to Present at Jefferies 2017 London Healthcare Conference
10/11/2017
DURHAM, N.C., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced that Alex Sapir, President and Chief Executive Officer, will present a company overview at the Jefferies 2017 [...]
Kamada Announces Nomination of Three New Members to its Board of Directors
10/11/2017
REHOVOT, Israel, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA ) (TASE: KMDA ), a plasma-derived protein therapeutics company focused on orphan indications, announced today that the Company Board of [...]
Aduro Biotech Announces Promising Preclinical Data that Validate Anti-CTLA-4 Antibody ADU-1604
10/11/2017
BERKELEY, Calif., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), a biopharmaceutical company with three distinct immunotherapy technologies, today announced data from preclinical studies with ADU [...]
Prophase Labs, Inc. Announces Intention to Commence Tender Offer to Repurchase Up to 1,700,000 Shares of Its Common Stock
10/11/2017
DOYLESTOWN, Pa., Nov. 10, 2017 (GLOBE NEWSWIRE) -- ProPhase Labs, Inc. (NASDAQ: PRPH ) ( www.ProPhaseLabs.com ), a diversified natural health medical science company (the “Company” or “ProPhase”), today announced that [...]
Galen Partners Completes Sale of Cambrooke Therapeutics
10/11/2017
STAMFORD, Conn., Nov. 10, 2017 (GLOBE NEWSWIRE) -- Galen Partners, a healthcare-focused, growth equity investment firm, announced today the sale of Cambrooke Therapeutics, Inc. (“Cambrooke”) to Ajinomoto Co. Cambrooke [...]
MacroGenics Announces Poster Presentations at 32nd Annual SITC Meeting 2017
10/11/2017
ROCKVILLE, Maryland, Nov. 10, 2017 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics [...]
IP veteran Andrew Filler joins BioSig Technologies’ Board of Directors
10/11/2017
Santa Monica, CA, Nov. 10, 2017 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (OTCQB: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
VBI Vaccines to Present New Preclinical Data for its GBM Immunotherapy, VBI-1901, at SITC 2017
10/11/2017
New data confirms use of intradermal delivery of eVLPs may be a potent “off-the-shelf” immunotherapy vaccine Poster presentation at the Society for Immunotherapy of Cancer’s (SITC) 32 nd Annual Meeting on Friday, [...]
India Globalization Capital Regains NYSE American Listing Compliance
10/11/2017
BETHESDA, Md., Nov. 10, 2017 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) announced that it received a letter on November 9, 2017 from NYSE Regulation stating that it is in compliance with [...]
Beleave Supports Recent Council Decision and Continues Expansion Uninterrupted
10/11/2017
TORONTO, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Beleave Inc. (“Beleave”) (CSE:BE) (OTCQX:BLEVF) strongly supports The City of Hamilton council’s decision to turn down the motion for any new restrictions pertaining to the [...]
HempTech (HTCO), a Nuvus Company, to Exhibit New Grow.Droid Line of Products, Artificial Intelligent (AI) grow systems and GrowComm App at Marijuana Business Conference & Expo in Vegas - Nov 15-17, Booth #2323
10/11/2017
Saint Petersburg, FL, Nov. 10, 2017 (GLOBE NEWSWIRE) -- HempTech Corp. (OTC PINK: HTCO), a provider of advanced Controlled Environment Agriculture (CEA) with sophisticated automation and analytical tools for the [...]
Myriad Collaborates with Department of Veterans Affairs in Large Trial Evaluating the GeneSight® Test to Improve Mental Health Outcomes for Veterans
10/11/2017
SALT LAKE CITY, Nov. 10, 2017 (GLOBE NEWSWIRE) -- Assurex Health, a wholly-owned subsidiary of Myriad Genetics, Inc. (NASDAQ: MYGN ), today announced that the Department of Veterans Affairs (VA) recently initiated a [...]

Pages